Royal Bank of Canada’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-3,012
| Closed | -$10K | – | 7478 |
|
|
2018
Q3 | $10K | Sell |
3,012
-2,988
| -50% | -$10.8K | ﹤0.01% | 6006 |
|
|
2018
Q2 | $23K | Buy |
6,000
+2,346
| +64% | +$11.4K | ﹤0.01% | 5491 |
|
|
2018
Q1 | $15K | Buy |
3,654
+1,041
| +40% | +$4.85K | ﹤0.01% | 5577 |
|
|
2017
Q4 | $12K | Sell |
2,613
-6,112
| -70% | -$33.7K | ﹤0.01% | 5812 |
|
|
2017
Q3 | $62K | Buy |
+8,725
| New | +$62.7K | ﹤0.01% | 5297 |
|
|
2017
Q2 | – | Sell |
-54,822
| Closed | -$338K | – | 6969 |
|
|
2017
Q1 | $338K | Sell |
54,822
-1,209
| -2% | -$6.62K | ﹤0.01% | 3955 |
|
|
2016
Q4 | $328K | Buy |
56,031
+55,945
| +65,052% | +$306K | ﹤0.01% | 4123 |
|
|
2016
Q3 | $0 | Sell |
86
-18
| -17% | -$97 | ﹤0.01% | 6704 |
|
|
2016
Q2 | $1K | Sell |
104
-2,600
| -96% | -$14.5K | ﹤0.01% | 6302 |
|
|
2016
Q1 | $13K | Sell |
2,704
-12,653
| -82% | -$50.5K | ﹤0.01% | 5655 |
|
|
2015
Q4 | $78K | Sell |
15,357
-92,823
| -86% | -$441K | ﹤0.01% | 5077 |
|
|
2015
Q3 | $381K | Buy |
108,180
+88,846
| +460% | +$595K | ﹤0.01% | 3786 |
|
|
2015
Q2 | $193K | Buy |
19,334
+8,271
| +75% | +$88.7K | ﹤0.01% | 4399 |
|
|
2015
Q1 | $141K | Sell |
11,063
-20,352
| -65% | -$262K | ﹤0.01% | 4433 |
|
|
2014
Q4 | $444K | Buy |
31,415
+5,846
| +23% | +$90.6K | ﹤0.01% | 3692 |
|
|
2014
Q3 | $352K | Buy |
25,569
+17,712
| +225% | +$271K | ﹤0.01% | 3787 |
|
|
2014
Q2 | $121K | Buy |
7,857
+1,285
| +20% | +$18.2K | ﹤0.01% | 4452 |
|
|
2014
Q1 | $112K | Sell |
6,572
-18,050
| -73% | -$272K | ﹤0.01% | 4494 |
|
|
2013
Q4 | $319K | Buy |
24,622
+23,599
| +2,307% | +$282K | ﹤0.01% | 3774 |
|
|
2013
Q3 | $10K | Buy |
+1,023
| New | +$9.1K | ﹤0.01% | 5433 |
|
Royal Bank of Canada's KERX Position: Q4 2018 in Review
Royal Bank of Canada sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 3,012 shares — an estimated $10K sold.
Royal Bank of Canada first reported a position in KERX in Q3 2013 and held it in 20 quarters. The position peaked at $444K in Q4 2014. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.
- Royal Bank of Canada reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
- Royal Bank of Canada sold 3,012 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $10K.
- Royal Bank of Canada first reported a position in Keryx Biopharmaceuticals Inc in Q3 2013 and held it in 20 quarters.
- Royal Bank of Canada's Keryx Biopharmaceuticals Inc position peaked at $444K in Q4 2014.
- 1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.
Based on Royal Bank of Canada's 13F filing for Q4 2018, filed 14 Feb 2019.